GMO International Value ETF (GMOI) seeks to provide long-term capital appreciation by investing in undervalued international stocks outside the United States. This actively managed value-focused ETF targets companies trading below their intrinsic worth based on fundamental analysis and quantitative screening metrics.
How It Works
GMOI employs GMO's proprietary active management approach, combining quantitative value screens with fundamental research to identify undervalued international equities. The fund uses multiple value metrics including price-to-book ratios, earnings yields, and cash flow measures to construct a concentrated portfolio. Portfolio managers actively adjust holdings based on valuation changes and market opportunities, with rebalancing occurring as needed rather than on fixed schedules.
Key Features
- Leverages GMO's 40+ year track record in value investing with proprietary quantitative models and fundamental research capabilities
- Recently launched in October 2024, offering 2.21% dividend yield from international value stocks with income potential
- Zero expense ratio structure makes it cost-competitive among actively managed international value strategies
Risks
- This ETF can lose value if international markets underperform U.S. markets or if value investing falls out of favor with investors
- Currency fluctuations can reduce returns when foreign currencies weaken against the U.S. dollar, adding volatility beyond stock performance
- Concentrated active management means performance depends heavily on GMO's stock selection skills, potentially lagging broad international market returns
Who Should Own This
Best suited for investors with 5+ year time horizons seeking international diversification through active value management. Requires medium-to-high risk tolerance due to international equity volatility and active management uncertainty. Works as satellite holding (10-20% of equity allocation) complementing core U.S. positions for experienced investors comfortable with GMO's value philosophy.